X0609 4 2026-05-04 1 0002114044 Hemab Therapeutics Holdings, Inc. COAG 0001388325 Novo Holdings A/S true TUBORG HAVNEVEJ 19 HELLERUP G7 DK-2900 DENMARK false false true false 0 Common Stock 2026-05-04 4 C 0 4180550 A 4180550 D Series Seed Preferred Stock 2026-05-04 4 C 0 23343 0 D Common Stock 513546 0 D Series A Preferred Stock 2026-05-04 4 C 0 71866 0 D Common Stock 1581052 0 D Series B Preferred Stock 2026-05-04 4 C 0 62121 0 D Common Stock 1366662 0 D Series C Preferred Stock 2026-05-04 4 C 0 32695 0 D Common Stock 719290 0 D Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration, on a 22-for-1 basis, and had no expiration date. /s/ Barbara Fiorini, General Counsel, Finance & Operations of Novo Holdings A/S 2026-05-06